TRIMETH/SULFA bulk active fine chemical sources

Subscribe to access the full database, or Get Started Free
Vendor	Vendor Homepage	Vendor Sku	API Url
Alinda Chemical Trade Company Ltd	⤷ Get Started Free	ALBB-002089	⤷ Get Started Free
Vitas-M Laboratory	⤷ Get Started Free	STK007988	⤷ Get Started Free
TCI (Tokyo Chemical Industry)	⤷ Get Started Free	S0361	⤷ Get Started Free
>Vendor	>Vendor Homepage	>Vendor Sku	>API Url

Last updated: August 5, 2025

Introduction

The combination of trimethoprim and sulfamethoxazole (commonly known as Trimeth / Sulfa) constitutes a widely prescribed antimicrobial agent used primarily for urinary tract infections, respiratory infections, and opportunistic infections such as Pneumocystis jirovecii pneumonia. As demand for this combination therapy continues to grow, especially in regions with robust generic drug markets, ensuring access to high-quality bulk APIs is critical for pharmaceutical manufacturers. This article provides a comprehensive review of key sources for bulk Trimethoprim and Sulfamethoxazole APIs, emphasizing quality, reliability, and regulatory considerations.

Overview of API Market for Trimethoprim and Sulfamethoxazole

The global API market for Trimethoprim and Sulfamethoxazole is characterized by a mixture of established chemical manufacturers, emerging producers in Asia, and API contract manufacturing organizations (CMOs). The primary factors influencing sourcing decisions include regulatory compliance, manufacturing capacity, cost efficiency, lead times, and quality assurance.

Major API Producers of Trimethoprim and Sulfamethoxazole

1. Indian API Manufacturers

India remains a dominant supplier of affordable APIs, including Trimethoprim and Sulfamethoxazole. Several companies have established GMP-certified production capabilities, adhering to international regulatory standards such as USFDA, EMA, and WHO-GMP.

a. Dishman Pharmaceuticals & Chemicals Ltd.

Product Overview: Dishman produces both Trimethoprim and Sulfamethoxazole APIs, with a focus on compliance with global regulatory standards.
Strengths: Consistent supply, GMP certified, with established export channels.

b. Micro Labs Ltd.

Product Overview: Offers high-quality Sulfamethoxazole API with comprehensive documentation for regulatory submissions.
Strengths: Proven regulatory track record and sizeable production capacity.

c. Solara Active Pharma Sciences Ltd.

Product Overview: Specializes in generic APIs, including Trimethoprim and Sulfamethoxazole, with a focus on timely delivery and quality control.

2. Chinese API Producers

China's API industry has gained prominence due to aggressive cost advantages and expanding manufacturing capabilities, including many WHO-GMP and ISO-certified facilities.

a. Zhejiang Haizheng Pharmaceutical Co.

Product Overview: Provides Sulfamethoxazole API with competitive pricing.
Strengths: Large-scale manufacturing, quality consistency, and flexibility in order quantity.

b. North China Pharmaceutical Group Corporation (NCPC)

Product Overview: Offers Trimethoprim API in addition to other antibiotics, backed by strong governmental support for quality improvements.

c. Zhejiang Hisun Pharmaceutical Co.

Product Overview: Supplies both APIs with robust regulatory dossiers, focusing on export markets.

3. European and North American Suppliers

While the majority of API manufacturing occurs in Asia, several European and North American firms supply premium APIs, primarily for regulated markets.

a. H. Lundbeck A/S (Denmark)

Product Overview: Known for high-purity, GMP-compliant APIs, including Trimethoprim.

b. BASF SE (Germany)

Product Overview: Offers Sulfamethoxazole APIs with a focus on high standards and supply chain stability.

c. Catalent Pharma Solutions (USA) and Boehringer Ingelheim (Germany):

Services: Provide custom manufacturing and bulk APIs to large pharmaceutical companies under strict quality controls.

Sourcing Considerations

Regulatory Compliance

Selecting a reputable supplier with current GMP, WHO-GMP, or equivalent certifications ensures API quality and streamlines regulatory approvals. Suppliers with robust quality assurance programs mitigate risks related to batch variability and contamination.

Quality Characteristics

Key parameters influencing API selection include purity (>99%), residual solvents, heavy metals, microbial limits, and conforming to pharmacopoeial standards (USP, BP, EP). Certificates of Analysis (CoA) and comprehensive dossiers are essential.

Supply Capacity and Lead Time

Manufacturers should evaluate supplier capacity relative to demand projections, ensuring consistent availability. Lead times should be factored into supply chain planning, especially amid global disruptions.

Pricing and Contract Terms

Cost competitiveness is essential, but should not compromise quality. Long-term contracts, volume discounts, and flexible terms can improve supply stability.

Emerging Trends in API Sourcing for Trimeth / Sulfa

Global Quality Initiatives: Increasing focus on quality standards in API manufacturing, driven by regulatory authorities, e.g., USFDA’s Drug Master Files (DMFs) and European F Acts.
Regulatory Harmonization: Suppliers aligning with multiple regulatory requirements facilitate market access in various regions.
Digitalization and Transparency: Digital platforms enable better supplier management, real-time tracking, and quality assurance.
Sustainable Manufacturing: Growing emphasis on green chemistry and environmentally friendly processes within API production facilities.

Challenges in API Sourcing

Regulatory Divergence: Varying regional requirements can complicate sourcing strategies.
Quality Variability: Ensuring batch-to-batch consistency remains a concern, especially with lower-cost suppliers.
Supply Chain Disruptions: COVID-19 pandemic underscored vulnerabilities in global supply chains, emphasizing the importance of diversified sourcing.
Intellectual Property (IP) and Proprietary Processes: Some manufacturers have patented processes; generic suppliers must navigate licensing agreements or develop equivalent processes.

Conclusion

Bulk API sourcing for Trimethoprim and Sulfamethoxazole hinges on balancing quality, regulatory compliance, cost, and supply stability. Indian and Chinese manufacturers comprise the bulk of global suppliers, supported by selective European and North American providers offering premium standards. Pharmaceutical companies must conduct rigorous supplier audits, verify certifications, and establish strategic partnerships to ensure an uninterrupted, compliant supply chain.

Key Takeaways

The Indian API industry is a primary source for affordable, compliant Trimethoprim and Sulfamethoxazole APIs, with major players like Dishman and Micro Labs.
Chinese API manufacturers offer competitive pricing and scalable production, with entities such as Zhejiang Haizheng and NCPC leading the market.
European and North American suppliers provide high-quality APIs suitable for regulated markets, with focus on product purity and regulatory adherence.
Sourcing strategies require thorough evaluation of quality standards, regulatory certifications, capacity, and lead times to mitigate supply risks.
Emerging trends emphasize quality harmonization, digital transparency, and sustainability, influencing future API sourcing landscapes.

FAQs

1. How do I verify the quality of a bulk API supplier?
Verify certifications such as GMP, WHO-GMP, and current regulatory filings (DMFs, CEPs). Conduct technical audits, review Certificates of Analysis, and request quality control data.

2. What are the main regulatory standards to consider when sourcing APIs?
Ensure APIs meet USP, EP, BP, or other regional pharmacopoeia standards, and that suppliers possess relevant GMP certifications recognized by regulatory bodies like USFDA or EMA.

3. Can small-volume orders be sourced reliably for Trimethoprim/Sulfamethoxazole?
While possible, smaller orders may have limited supplier options, and lead times can be longer due to manufacturing batch sizes. Larger, consistent volumes often ensure better reliability.

4. What impact has the COVID-19 pandemic had on API supply chains?
It highlighted vulnerabilities, leading to supply disruptions, especially from China. Diversification and multi-source sourcing are recommended strategies moving forward.

5. Are there any upcoming regulatory changes impacting API sourcing for antibiotics?
Regulatory bodies increasingly emphasize quality standards, environmental sustainability, and transparency. Changes vary regionally but generally aim to improve drug safety and supply chain integrity.

References

U.S. Food and Drug Administration (FDA). Current Good Manufacturing Practice (CGMP) Regulations.
European Medicines Agency (EMA). Guidelines on Good Manufacturing Practices.
Market research reports on global API industry.
Company websites and regulatory filings of major API manufacturers.
WHO. Guidelines on the Quality, Safety, and Efficacy of Medicines in International Procurement.

Bulk Pharmaceutical API Sources for TRIMETH/SULFA